Vital-Reyes VS, Carrillo-Martínez CR, Hinojosa-Cruz JC, Martínez-Basilia A, López-Alarcón M

Language: Spanish
References: 12
Page: 785-790
PDF size: 350.02 Kb.

ABSTRACT

Objective: To assess IR in PCOS patients, using the HE-clamp as the IR gold standard.
Material and Methods: A transversal design was done. All patients who accepted to participate provided written informed consent. PCOS was diagnosed according to the 2003 Rotterdam criteria. IR was assessed using the H- clamp, and other IR surrogates such as; fasting plasma insulin (FPI), homeostasis model assessment (HOMA) index and insulin/ glucose rate (I/G rate). Statistical analysis was performed using measures of location and spread was used according to data distribution.
Results: 21 patients were included. The mean age of the total group studied was 29.5 ± 4.8 years, and the body mass index (BMI) was 27.2 ± 3.08 kg/m². The 85.7% of the patients met the three Rotterdam criteria for the diagnosis of PCOS. According to the HE clamp 95.2% were IR (M/I value ‹ 6mg/Kg/min), in contrast the prevalence of IR using surrogates was 47.6%, 33.3%, and 66.6% for FPI, G/I rate, and HOMA index respectively.
Conclusions: Our findings show that IR is highly prevalent in patients with PCOS, and that this prevalence is even higher when insulin sensitivity is assessed using the glucose clamp technique. This evidence suggests that IR could be considered diagnostic criteria for PCOS.

REFERENCES

1. Azzis R, Sanchez LA, Knochenhauer ES, Moran C, Lazanby J. Androgen excess in women: experience with over 1,000 consecutive patients. J Clin Endocrinol Metab 2004;89:453-462.

2. Abdul- Ghani MA. Matsuda M, Bogdan B, De Fronso RA. Muscle and liver insulin resistance indexes obtained from de oral glucose tolerance test. Diabetes Care 2007;30:89- 94.

3. Romaguera J, Moran C, Diaz-Montes TP, Hines GA, Cruz RI. Prevalence of 21-hydroxylase-deficient nonclassic adrenal hiperplasia and insulin resistance among hirsute women from Puerto Rico. Fertile Steril 2000;74:59-62.

4. Carmina E, Koyama T, Chang L. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gyn 1992;167:1807-1812.

5. Chang RJ, Nakamura RM, Judd HL. Insulin resistance in nonobese patients whit polycystic ovarian disease. J Clin Endocrinol Metab 1983;57:356-359.

6. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-2698.

7. Moran C, Garcia-Hernandez E, Barahona E, González S, et al. Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome. Fertil Steril 2003;80:1466-1472.

8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA. Insulin Resistance and B cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-419.

9. Elahi D. Praise of the Hyperglycemic Clamp: A Method for Assessment of Beta –Cell sensitivity and insulin Resistance. Diabetes Care 1996;19:278-286.

10. The Rotterdam ESHRE / ASRM- Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.

11. Size of sample. In: Statistical Methods. Snedecor GW and Cochran WG. 8th ed. Iowa: Iowa State University Pres. 1989;52-53.

12. Jonard S, Dewally D. The follicular excess in polycystic ovaries, due to intra-ovarian hiperandrogenism, may be the main culprit for the follicular arrest. Human Reprod Update 2004;10:107-117.